Entrada Therapeutics Inc. (TRDA)
NASDAQ: TRDA
· Real-Time Price · USD
5.29
0.04 (0.76%)
At close: Aug 15, 2025, 3:59 PM
5.27
-0.28%
After-hours: Aug 15, 2025, 04:10 PM EDT
Entrada Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -73.35M | 24.78M | 65.63M | 54.95M | 104.44M | 23.48M | -6.68M | -21.77M | -82.37M | -79.62M | -94.62M | -88.43M | -77.73M | -64.45M | -51.16M | -41.38M | -33.94M | -29.47M |
Depreciation & Amortization | 3.91M | 3.79M | 3.77M | 3.52M | 3.41M | 3.23M | 2.84M | 2.63M | 2.31M | 2.05M | 1.9M | 1.73M | 1.52M | 1.31M | 1.12M | 851K | 639K | 456K |
Stock-Based Compensation | 19.7M | 19.27M | 17.91M | 17.06M | 15.59M | 14.09M | 13.11M | 12.15M | 11.46M | 10.86M | 9.89M | 8.47M | 6.34M | 4.16M | 2.53M | 1.17M | 663K | 413K |
Other Working Capital | -55.27M | -168.27M | -122.04M | -86.98M | -130.37M | -49.88M | 135.95M | 128M | 186.34M | 193.79M | -16.4M | -8.64M | -6.77M | -6.36M | -2.71M | 2.02M | 3.56M | 1.12M |
Other Non-Cash Items | -25.38M | -9.32M | -10.02M | -5.75M | -4.39M | -3.82M | -2.02M | -3.88M | -2.06M | -228K | 151K | 175K | 358K | 216K | 74K | 166K | 13K | 172K |
Deferred Income Tax | n/a | n/a | n/a | -3.76M | -3.76M | -3.76M | -3.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -48.74M | -93.06M | -118.85M | -79.98M | -129.49M | -122.34M | 136.31M | 127.38M | 184.18M | 197.55M | -11.11M | -8.97M | -4.11M | -4.75M | -3.42M | 2.26M | 4.11M | 1.18M |
Operating Cash Flow | -123.87M | -54.55M | -41.56M | -13.96M | -14.19M | -89.11M | 139.8M | 116.51M | 113.52M | 130.6M | -93.79M | -87.02M | -73.62M | -63.52M | -50.86M | -36.95M | -28.52M | -27.26M |
Capital Expenditures | -2.69M | -3.46M | -3.16M | -3.5M | -4.31M | -4.78M | -5.61M | -5.35M | -4.71M | -3.96M | -2.89M | -3.5M | -3.5M | -4.27M | -4.58M | -4.71M | -4.14M | -2.91M |
Cash Acquisitions | n/a | n/a | n/a | -152.8M | -150.51M | -38.78M | n/a | 152.8M | 159.84M | 48.1M | 9.32M | 9.32M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -326.66M | -420.8M | -437.72M | -461.74M | -372.94M | -402.37M | -407.21M | -318.69M | -281.22M | -141.1M | -221.98M | -221.98M | -182.65M | -182.65M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 338.38M | 375.1M | 413.08M | 403.12M | 394.31M | 335.35M | 274.43M | 185.39M | 140.89M | 137.5M | 76.21M | 56.71M | 26.71M | 1.71M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -23.34M | 3.65M | 23.67M | 21.38M | -67.02M | -132.78M | -133.3M | -140.34M | -3.6M | 35.18M | 15.68M | 25M | n/a | n/a | n/a | n/a | 3.5K |
Investing Cash Flow | 9.02M | -49.16M | -27.8M | -62.12M | 17.07M | -71.8M | -138.4M | -138.65M | -145.04M | -7.56M | -148.65M | -168.76M | -159.44M | -185.21M | -4.58M | -4.71M | -4.14M | -2.91M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 317K | n/a | n/a | 443K | 443K | 443K | 443K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.13M | 103.5M | 103.36M | 102.64M | 102.63M | 1.71M | 1.63M | 1.3M | 990K | 558K | 479K | 190.88M | 190.92M | 191.13M | 191.21M | 607K | 501K | 12.82M |
Financial Cash Flow | 2.08M | 103.11M | 102.96M | 102.25M | 102.63M | 1.71M | 21.04M | 20.7M | 20.4M | 19.96M | 479K | 190.88M | 190.92M | 191.13M | 307.46M | 116.86M | 141.61M | 153.94M |
Net Cash Flow | -112.77M | -599K | 33.61M | 26.17M | 105.51M | -159.21M | 22.45M | -1.43M | -11.12M | 143.01M | -241.96M | -64.91M | -42.13M | -57.6M | 252.02M | 75.2M | 108.96M | 123.77M |
Free Cash Flow | -126.56M | -58.01M | -44.72M | -17.46M | -18.5M | -93.9M | 134.19M | 111.17M | 108.81M | 126.64M | -96.67M | -90.52M | -77.11M | -67.78M | -55.44M | -41.65M | -32.66M | -30.17M |